Related references
Note: Only part of the references are listed.Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk
Liam D. Cassidy et al.
NATURE COMMUNICATIONS (2020)
Role of Immunotherapy in Triple-Negative Breast Cancer
Tanya E. Keenan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Recent advances in triple negative breast cancer: the immunotherapy era
Antonio Marra et al.
BMC MEDICINE (2019)
Tenascin-C Produced by Intestinal Myofibroblasts Promotes Colitis-associated Cancer Development Through Angiogenesis
Takafumi Kawamura et al.
INFLAMMATORY BOWEL DISEASES (2019)
The multifaceted role of autophagy in cancer and the microenvironment
Hendrik Folkerts et al.
MEDICINAL RESEARCH REVIEWS (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
Sachet A. Shukla et al.
CELL (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inflammatory signaling cascades and autophagy in cancer
Teresa Monkkonen et al.
AUTOPHAGY (2018)
Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)
Lin Jiao et al.
AUTOPHAGY (2018)
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao et al.
CLINICAL CANCER RESEARCH (2017)
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng et al.
CANCER DISCOVERY (2016)
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Federico Pietrocola et al.
CANCER CELL (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses
Meixin Chen et al.
MOLECULAR CELL (2016)
Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma
Zhao-Ting Yang et al.
PLOS ONE (2016)
Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation
Elena Jachetti et al.
CANCER RESEARCH (2015)
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis
Hao Tang et al.
EBIOMEDICINE (2015)
Ubiquitylation of Autophagy Receptor Optineurin by HACE1 Activates Selective Autophagy for Tumor Suppression
Zhengzhao Liu et al.
CANCER CELL (2014)
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells
Seth M. Pollack et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
John Stagg et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
Jun Tang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Blocking Hypoxia-Induced Autophagy in Tumors Restores Cytotoxic T-Cell Activity and Promotes Regression
Muhammad Zaeem Noman et al.
CANCER RESEARCH (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Expression of tenascin-C and its isoforms in the breast
David S. Guttery et al.
CANCER AND METASTASIS REVIEWS (2010)
Extracellular Matrix of Glioblastoma Inhibits Polarization and Transmigration of T Cells: The Role of Tenascin-C in Immune Suppression
Jyun-Yuan Huang et al.
JOURNAL OF IMMUNOLOGY (2010)
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
DA Rizzieri et al.
BLOOD (2004)
Tenascin-C suppresses Rho activation
MB Wenk et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
